At a glance
- What the study gets you
- Health checks and monitoring — no treatment given
- Type of study
- Observational (no treatment given)
- Time in hospital
- In-person visits at study sites — visit count not specified by the sponsor
- Drug or intervention
- Not specified by the sponsor
- How long the study runs
- Study runs about 66 months (dates as stated)
- About the drug or intervention
- Not specified by the sponsor
- Patient visit burden
- Not specified by the sponsor
- Type of study
- Observing health over time
- Ages
- 18 Years and over
- Who
- All
- Number of participants
- 230
- Started
- 2024-02-08
- Last checked
- 2026-06
Plain English Summary
What is this study?
- • Testing a new treatment for copd
- • Clinical study - 230 participants
- • There are over 700,000 UK hospital admissions every year with lung disease symptoms
Who can take part?
- • Ages 18 Years and over
- • Diagnosed with copd
Where?
- • London - Guy's & St Thomas' NHS Foundation Trust
This is a simplified summary. Always discuss with your doctor before making any decisions.
About This Trial
There are over 700,000 UK hospital admissions every year with lung disease symptoms. Two of the most common lung diseases contributing to these numbers are asthma and chronic obstructive pulmonary disease (COPD). The immunopathology of these diseases is not fully understood. Matched samples from the respiratory tract and circulation will be used to identify immune patterns throughout the respiratory system to elucidate the immunopathology of airway disease.
More detail
In this observational study, we will be enrolling patients with diagnosed or suspected airways disease who are over 18 years old, as well as age matched healthy volunteers with no significant illness. Participants will be asked if they consent to enter the study, invited at clinically relevant time points (treatment change, disease exacerbation etc.) and to optional bronchoscopy visits. It is expected that participants will be seen yearly with any additional exacerbation/treatment visits also recorded. Research visits will occur at King's College London and the Guys and St Thomas' NHS Foundation Trust (GSTFT), with all bronchoscopy visits occurring within GSTFT 1. Disease specific questionnaires. 2. Lung function tests including spirometry or oscillometry (if not performed previously within 6 months) 3. Sputum collection 4. Nasal sampling including nasosorption, nasal brushing, nasal lavage, or nasopharyngeal swabs 5. Exhaled breath 6. Blood samples (\<6 tablespoons) Optional 7. Bronchoscopy involving a flexible fibreoptic camera passed into the lungs to collect bronchoalveolar lavage, bronchosorption, bronchial brushings and bronchial biopsies. 8. To repeat these procedures at later time - expected once per year or at times of clinically relevant changes
How this trial compares with your answers
Answer 2 more questions to improve match
What we know so far
Still need:
- • Tell us your age for better matching
- • Tell us your sex for better matching
Preliminary match based on your answers. Full eligibility requires on-site assessment including medical history, physical exam, and lab tests. This does not guarantee enrolment.
Eligibility at a Glance
Key info
- Age: 18 Years and over
- Who can join: All genders
What the study is looking for
- ✓Participant is willing and able to give agreement to take part for participation in the study
- ✓Aged 18 years or above
- ✓Patient: known or suspected airway disease
- ✓Healthy volunteer: considered to be in good health with no significant other health condition (immune disorder, cancer etc.)
Who cannot take part
- ✗Known or suspected current lung tuberculosis, HIV (human immunodeficiency virus), Hepatitis B Virus, Hepatitis...
- ✗Surgery within the preceding 6 weeks
- ✗Participants who are pregnant
- ✗Alcohol or recreational drug abuse
- ✗Diagnosis of immunodeficiency requiring treatment
See the full criteria
Where Is This Study? (1 UK site)
Guy's & St Thomas' NHS Foundation Trust
London SE1 9RT, United Kingdom
How to Get in Touch
Gillian Radcliffe, MRes
Sponsor contactCONTACT
Steven Cass, PhD
Sponsor contactCONTACT
